Patents by Inventor Benjamin P. Fauber

Benjamin P. Fauber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8362283
    Abstract: The present invention relates to methods for the synthesis of galanthamine, morphine, intermediates, salts and derivatives thereof. In preferred embodiments, the invention relates to methods for improving the efficiency and overall yield of said morphine, morphine related derivatives and intermediates thereof. In further embodiments, the invention relates to methods for improving the efficiency and overall yield of galanthamine and intermediates thereof.
    Type: Grant
    Filed: May 12, 2010
    Date of Patent: January 29, 2013
    Assignee: Board of Regents, The University of Texas System
    Inventors: Philip D. Magnus, Benjamin P. Fauber, Neeraj Sane
  • Patent number: 8293927
    Abstract: The present invention relates to methods for the synthesis of morphine, intermediates, salts and derivatives thereof. In preferred embodiments, the invention relates to methods for improving the efficiency and overall yield of said morphine, morphine related derivatives and intermediates thereof. In further embodiments, the invention relates to methods for improving the efficiency and overall yield of galanthamine and intermediates thereof.
    Type: Grant
    Filed: May 12, 2010
    Date of Patent: October 23, 2012
    Assignee: Board of Regents the University of Texas System
    Inventors: Philip D. Magnus, Benjamin P. Fauber, Neeraj Sane
  • Publication number: 20100292489
    Abstract: The present invention relates to methods for the synthesis of galanthamine, morphine, intermediates, salts and derivatives thereof. In preferred embodiments, the invention relates to methods for improving the efficiency and overall yield of said morphine, morphine related derivatives and intermediates thereof. In further embodiments, the invention relates to methods for improving the efficiency and overall yield of galanthamine and intermediates thereof.
    Type: Application
    Filed: May 12, 2010
    Publication date: November 18, 2010
    Inventors: Philip D. Magnus, Benjamin P. Fauber, Neeraj Sane
  • Publication number: 20100292475
    Abstract: The present invention relates to methods for the synthesis of morphine, intermediates, salts and derivatives thereof. In preferred embodiments, the invention relates to methods for improving the efficiency and overall yield of said morphine, morphine related derivatives and intermediates thereof. In further embodiments, the invention relates to methods for improving the efficiency and overall yield of galanthamine and intermediates thereof.
    Type: Application
    Filed: May 12, 2010
    Publication date: November 18, 2010
    Inventors: Philip D. Magnus, Benjamin P. Fauber, Neeraj Sane
  • Publication number: 20100292466
    Abstract: The present invention relates to methods for the synthesis of galanthamine, morphine, intermediates, salts and derivatives thereof. In preferred embodiments, the invention relates to methods for improving the efficiency and overall yield of said morphine, morphine related derivatives and intermediates thereof. In further embodiments, the invention relates to methods for improving the efficiency and overall yield of galanthamine and intermediates thereof.
    Type: Application
    Filed: May 12, 2010
    Publication date: November 18, 2010
    Inventors: Philip D. Magnus, Benjamin P. Fauber, Neeraj Sane
  • Patent number: 6392076
    Abstract: A compound comprising a polyfluorinated anion and the use thereof is provided. Specifically, the present invention provides a compound comprising an anion which comprises a polyfluorinated alkoxide coordinated to a transition metal, or a Group III, IV or V element.
    Type: Grant
    Filed: March 10, 2000
    Date of Patent: May 21, 2002
    Assignee: Colorado State University Research Foundation
    Inventors: Steven H. Strauss, Benjamin P. Fauber, Benjamin G. Nolan